EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice
about
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimagingGlioblastoma multiforme--treating a deadly tumor with both strands of RNAThe Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to BrainOptimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systemsEpidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.Replicase-based plasmid DNA shows anti-tumor activity.EGFR-homing dsRNA activates cancer-targeted immune response and eliminates disseminated EGFR-overexpressing tumors in mice.Targeting the Immune System to Fight Cancer Using Chemical Receptor Homing Vectors Carrying Polyinosine/Cytosine (PolyIC).Control of solid tumor growth in mice using EGF receptor-targeted RNA replicase-based plasmid DNA.Programmed drug delivery: nanosystems for tumor targeting.Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.PolyIC GE11 polyplex inhibits EGFR-overexpressing tumorsGene therapy progress and prospects: synthetic polymer-based systems.A peptide-mediated targeting gene delivery system for malignant glioma cells.Localized irradiation of tumors prior to synthetic dsRNA therapy enhanced the resultant anti-tumor activity"Selective cell death mediated by small conditional RNAs" is not selective.Glioma stem cell signaling: therapeutic opportunities and challenges.Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis.Ginsenoside Rh2 inhibits growth of glioblastoma multiforme through mTor.Inhibition of FoxO1 nuclear exclusion prevents metastasis of glioblastoma.EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2.Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastoma.mRNA stability alterations mediated by HuR are necessary to sustain the fast growth of glioma cells.Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activation.Poly(I:C)-mediated tumor growth suppression in EGF-receptor overexpressing tumors using EGF-polyethylene glycol-linear polyethylenimine as carrier.PSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responsesPSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice.Nucleic acid therapeutics: concepts for targeted delivery to solid tumors
P2860
Q21223671-9F302F10-8D41-4D7A-84CC-55578010B928Q24815031-485CD042-3E9C-4067-8FE8-F8AF19774C7AQ26745586-5D325B67-B61A-4F70-8C46-3CF02A8A1C28Q28476268-52111AAB-262C-4F8C-BC2B-87DC592CE0E8Q34757186-A5FB65A0-C8FF-42FA-920A-F689419401E2Q34778611-9F2B3157-1D4A-4852-9515-FC2C8918517EQ34813939-082F1E7A-65A2-43B9-A978-7865CAA1FF2FQ35971366-3EA3DCEB-E5D8-4C39-9351-0851EAEB35ECQ36471407-F87A06EF-4C64-42A1-A92F-87CB9FCD5AD7Q36810261-A8A7F66D-43F0-4299-897F-DF75CB7DC50EQ36838803-FFF9751D-1432-4511-AB7D-A4E2BEA96C6BQ37014230-B12A019F-8FED-46A8-899B-DA5A7C205C32Q37182756-F676C678-2DFD-4710-B0CD-84F060281F5EQ37216016-6E805687-928F-460C-9DF0-A347C581F8A5Q37340979-6FF27ED4-0E43-4F99-9170-D0C09A96D52CQ37344453-5ECFD0F7-E134-4288-8FF5-DF0398D64750Q37752381-366A7986-54F3-434C-BDDE-056F9583F04AQ37850458-3D4D484B-FE1A-4CAD-97C5-A95E673B71EFQ38937209-24D630DC-0B2D-4D6C-9FEF-F9EB3D168B4EQ39000877-4372D280-26B2-4488-BFFC-BC561C48DDADQ39021976-70364AC5-D606-48A5-8503-8C92A03C59E5Q39198219-C209CD8B-5A08-49F7-BC21-D7AE152A1D07Q39470558-BF3BE89B-3239-4825-8380-02FF6D3D0DBBQ39530004-0E003174-CB66-46A1-B81B-0B9D5305CB51Q39669738-5D544E6B-125A-4C11-A1C2-C980D987BEA8Q42114642-B7F99B79-E585-4D3F-A692-EFE01DC35B94Q49920174-415ED0E5-3289-4CD3-AF8F-C4F67304B42DQ57372842-2CD22D0D-27AB-45F8-B0B0-02072B110B31
P2860
EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
EGF receptor-targeted syntheti ...... adenocarcinoma tumors in mice
@ast
EGF receptor-targeted syntheti ...... adenocarcinoma tumors in mice
@en
EGF receptor-targeted syntheti ...... adenocarcinoma tumors in mice
@nl
type
label
EGF receptor-targeted syntheti ...... adenocarcinoma tumors in mice
@ast
EGF receptor-targeted syntheti ...... adenocarcinoma tumors in mice
@en
EGF receptor-targeted syntheti ...... adenocarcinoma tumors in mice
@nl
prefLabel
EGF receptor-targeted syntheti ...... adenocarcinoma tumors in mice
@ast
EGF receptor-targeted syntheti ...... adenocarcinoma tumors in mice
@en
EGF receptor-targeted syntheti ...... adenocarcinoma tumors in mice
@nl
P2093
P2860
P1433
P1476
EGF receptor-targeted syntheti ...... adenocarcinoma tumors in mice
@en
P2093
Alexander Levitzki
Alexei Shir
Manfred Ogris
P2860
P356
10.1371/JOURNAL.PMED.0030006
P407
P50
P577
2005-12-06T00:00:00Z